Nanjing Vazyme Biotech Co Ltd (688105) — Cash Flow Quality Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Quality Index of 21.60x as of September 2025. Operating cash flow of CN¥75.30 Million exceeds net income of CN¥3.49 Million, indicating high earnings quality where cash backs reported profits. Explore 688105 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nanjing Vazyme Biotech Co Ltd Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 688105 operating cash flow.
Annual Cash Flow Quality Index for Nanjing Vazyme Biotech Co Ltd (2017–2022)
Year-by-year earnings quality comparison for Nanjing Vazyme Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.24x | CN¥735.17 Million | CN¥593.51 Million | ▲ +36.2% |
| 2021 | 0.91x | CN¥616.80 Million | CN¥678.29 Million | ▼ -7.0% |
| 2020 | 0.98x | CN¥803.55 Million | CN¥821.73 Million | ▲ +65.9% |
| 2019 | 0.59x | CN¥15.20 Million | CN¥25.79 Million | ▲ +115.3% |
| 2018 | -3.85x | CN¥-4.00 Million | CN¥1.04 Million | ▼ -263.5% |
| 2017 | -1.06x | CN¥-3.86 Million | CN¥3.64 Million | — |